Copyright © 2021 Blue Coast Research Center | All Rights Reserved.

george m whitesides net worth

  /  yaxie lotte face reveal   /  george m whitesides net worth

george m whitesides net worth

Reputation Score: 1.49 - 3.12. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $43,960 and over the last 9 years he sold TBPH stock worth over $0. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. , The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . of 0 shares. Interim CFO Brian Piekos American chemist and professor of chemistryWhitesides is currently 81 years and running. [35] He ranked 5th on Thomson ISI's list of the 1000 most cited chemists from 1981 to 1997,[36] and 38th on the list from 2000 to 2010. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Slow Crack Growth in Single-Crystal Silicon. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. SVP & Chief Financial Officer Aziz Sawaf . Verified email at gmwgroup.harvard.edu - Homepage. [51][52] In November 2009, he was recipient of the Reed M. Izatt and James J. Christensen Lectureship. George M. Whitesides. 2020-21 Jimmy Murphy Young Player of the Year. Haihui Joy Jiang. and 3 Net Worth, Salary, House. Whitesides Current research interests include physical and organic chemistry, complexity and simplicity, materials science, biophysics, technology for developing economies, biology tools, and lifes origin. sale PMID: 20000334 DOI: 10.1021/ac9013989 Abstract Microfluidic paper-based analytical devices (microPADs) are a new class of point-of-care diagnostic devices that are inexpensive, easy to use, and designed . George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,840 and over the last 8 years he sold TBPH stock worth over $0. Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The committee developed four areas of recommendations, with twenty specific proposals for implementable actions. degree from Harvard College in 1960 and earned a Ph.D. in chemistry from the California Institute of Technology in 1964, where he worked with John D. WATCH. You can help Wikipedia by expanding it. 193983. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. There are 1 older and 26 younger executives at Theravance Biopharma Inc. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS. [13], Whitesides is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the National Academy of Engineering. Bei Erweiterung erscheint eine Liste mit Suchoptionen, die die Sucheingaben so ndern, dass sie zur aktuellen Auswahl passen. He still serves as a member of the Virgin Galactic Advisory Board. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. He is particularly well known for his work in materials and surface science. The largest trade he's ever made was buying 4,000 units of Theravance Biopharma Inc stock on 11 August 2017 worth over $98,760. TEDTalking Nano- Perspectives on . Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. [17] Some of his research has been visually presented through the collaboration On the Surface of Things: Images of the Extraordinary in Science with MIT science photographer Felice Frankel. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $41,840 and over the last 9 years he sold TBPH stock worth over $0. In summary, during the past 3 months, insiders sold 50,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net Dr. Whitesides was a 1998 recipient of the National Medal of Science. . The paper wicks bodily fluids-urine, which turns color to provide diagnostic information, such as how much glucose or protein is present. Other transactions such as conversion of derivative security or exercise of options are not included. You can help our author matching system! Identities Podcasts People Ai. Whitesides continued his work with NMR spectroscopy and organometallic compounds working with polymers (substance consisting of very large molecules). and The most-recent trade in Theravance Biopharma Inc is the , [8] He used NMR spectroscopy to study rate of change of Grignard reagents[9] and the structure of Grignard reagents in solution. of 11,026,781 shares. Whitesides was the Chairman of the Reusable Launch Vehicle Working Group of COMSTAC, the advisory committee for the FAA's Commercial Space Transportation Division. Whitesides George M Net Worth 2022 and insider trades. , He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. a net He received an A.B. He joined the Department of Chemistry of . a net You can see the complete history of George Whitesides stock trades at the bottom of the page. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. Last edited on 24 February 2023, at 15:19, National Aeronautics and Space Administration, "Virgin Galactic changing CEOs, bringing on Disney's Michael Colglazier", "Virgin Galactic Snags NASA Chief of Staff as CEO", "Whitesides steps down from Virgin Galactic", "Virgin Galactic Appoints George Whitesides as Senior Advisor", https://en.wikipedia.org/w/index.php?title=George_T._Whitesides&oldid=1141337556, This page was last edited on 24 February 2023, at 15:19. Roberts) in 1964. His lab work that focuses on materials science involves the fabrication of nanostructures, microfluidic systems, microelectromechanical systems, and 3-D microstructures. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,280 and over the last 9 years he sold TBPH stock worth over $0. Interim CFO Brian Piekos George Thomas Whitesides is an American businessman. , Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. [33] Many in the scientific community asserted that research agendas should be "disinterested" and that education must focus on fundamental research to advance. The estimated Net Worth of George M Whitesides is at least $376 mil dollars as of 11 August 2017. On average, Theravance Biopharma Inc executives and independent directors trade stock every 67 days with the average trade being worth of $170,082. . The estimated Net Worth of George M Whitesides is at least $380 Tisc dollars as of 11 August 2017. Advisory Committee for Lincoln Laboratory (1985-2004); Scientific Advisory Committee for the Scripps Research Institute (1993-7); Sandia Science and Technology Advisory Board (2002-04, 2006-09); Sandia NWEAB (2004-07); Intelligence Science Board (2003-08); Committee on Science at Brandeis (2004-5, chairman); Institute for Soldier Nanotechnology (ISN, MIT, 2005-08); Advisory Committee for the Materials Research Center (U. Illinois/DoE, 2005-07); MIT Visiting Committee for Chemistry (2010-2012); Instute for Justice (Department of Justice) (2011-); Advisory Committee for Lawrence Berkeley National Laboratory (2011-); JCESR's Energy Storage Advisory Committee, Argonne National Laboratory (2012-). sale He was part of the Committee on Science, Engineering, and Public Policy, which authored the National Academies' report Rising Above the Gathering Storm (2007). [40], Among other awards, Whitesides is the recipient of the American Chemical Society's ACS Award in Pure Chemistry (1975),[41] the Arthur C. Cope Award (1995),[42] National Medal of Science (1998),[43][44] the Kyoto Prize in Materials Science and Engineering (2003),[45] the Gabbay Award (2004),[46] the Dan David Prize (2005),[47] the Welch Award in Chemistry (2005),[48] the AIC Gold Medal (2007),[49] and the Priestley Medal (2007), the highest honor conferred by the ACS. History at Harvard University is noted for its diversity, creativity, and productivity, and for the quality of the students, it produces. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net , The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. He has an MPhil in Geographical Information Systems and Remote Sensing from King's College, Cambridge. On average, George trades about 364 units every 0 days since 2014. NEXT ARTICLE. Other key executives at AMAG Pharmaceuticals Inc include The firm collaborates with and receives funding from GlaxoSmithKline. George Whitesides"Whitesides . [57][58] In 2013 he was awarded the IRI Medal alongside Robert S. An icon used to represent a menu that can be toggled by interacting with this icon. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . George M Whitesides is the director of Innoviva Inc. 12 Jun 1992. Addressing human, financial, and informational issues, the report argued in favor of:[27], In 2002, Whitesides served as the Chairman of the International Review Panel that evaluated the state of chemical research in the United Kingdom. the Director of Theravance Biopharma Inc and owns about 237,054 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Last updated: 29 April 2021 at 6:18pm EST. You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. George Whitesides, former Virgin Galactic CEO, is running for Congress in California. From 1982 to 1991 he was a member of the Department of Chemistry at Harvard University and Chairman of the Department of Chemistry from 1986 to 1989. A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. Fundamental company data provided by Morningstar, updated daily. Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table. 7 Rumors and Controversies. According to the SEC Form 4 filings, George M Whitesides has made a total of , 1539-1541. [30] He is also a member of the Reliance Innovation Council formed by Reliance Industries Limited, India. Net Worth. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 11,026,781 shares were bought by its insiders, resulting in a net The most active insiders traders include Plc Gsk, Inc. Innoviva, e Deepika Pakianathan. [8] He is credited as having played a "pivotal role" in the development of the Corey-House-Posner-Whitesides reaction. They recommended that institutions focus on practical problems, and teach entrepreneurial skills along with basic science so as to stimulate the development of practical technologies, encouraging students to take ownership of their own research. He has been Woodford L. and Ann A. GMW. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. 1100+100040. [8] He was the Mallinckrodt Professor of Chemistry from 1982 to 2004. Chief Medical Officer Richard Nieman . He ended up remaining in Massachusetts to attend Harvard University as an undergraduate. Identities Podcasts. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Niagara Falls, NY. (2022) Charge Transport Measured Using the EGaIn Junction through Self-Assembled Monolayers Immersed in Organic Liquids.The Journal of Physical Chemistry. As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. sale According to Whitesides, benefits and the risks of nano and microtechnology from the potential of quantum computers and single-molecule genomic sequencers considering no any matter according to as understandable and clear as possible, the practical and probable realities of nanoscience provides a unique vision of work at the very boundaries of modern science. Whitesides was Virgin Galactic's CEO from 2010 to 2020, before shifting to a role as the company's chief space officer last year when the company brought on Michael Colglazier as CEO. From 1982 to 1991 he was a member of the Department of Chemistry at Harvard University and Chairman of the Department of Chemistry from 1986 to 1989. Southern Cal: The Trojans, 44 th in the NET, are 21-8, 13-5 in . Haihui Joy Jiang . Check out Loretta Hidalgo Whitesides's net worth in US Dollar Feb, 2023. [11] At Harvard, Whitesides has served as chairman of the Chemistry Department (198689)[12] and Associate Dean of the Faculty of Arts and Sciences (198992). N.C. State, 22-9, 12-8 in the Atlantic Coast Conference, is finished until the ACC Tournament. , $421 thousand. 1964 (Caltech . Net worth score. GuruFocus also compares George M Whitesides's trading performance to market benchmark return within the same time period. George McClelland Whitesides"" no insider transaction in Lyra Therapeutics Inc (LYRA). It was chemistry to solve problems, not necessarily to do chemistry. No Small Matter: An overview was offered to Authors Felice C. Frankel and George M. Whitesides of recent scientific advances, which gives us our ever-shrinking microtechnology for instance, an information processor connected by wires only 1,000 atoms wide. 7. Most recently he bought 4,000 units of TBPH stock worth $98,760 on 11 August 2017. In his legendary career in chemistry, George Whitesides has been a pioneer in microfabrication and nanoscale self-assembly. Scientific Advisory Boards (2010 - present): MC-10, Sun Catalyix, Reliance Corporation (India, 2009-2016); NextGen Jane (2014- ); Breakthrough Energy Ventures (2017 -); Jana Care (2017 -)Boards of Directors (2000 - present; *= current)Genzyme (co-founder), Rohm and Haas, Dexter, Hughes Research Laboratory, Advanced Magnetics, Assemblon, Concurrent Biomedical, Theravance*, Theravance Biopharma*, Surface Logix, Nano-Terra (Founder)*, Arsenal Vascular*, Lyra Therapeutics* Diagnostics for All (501-c-3, Founder)*, MC 10 Corporation, Soft Robotics (Founder)*Editorial BoardsAngewandte Chemie, Langmuir, Small, Lab on a Chip, Soft Robotics.Research InterestsChemistry, materials science, biophysics, the role of water in biomolecular recognition, the hydrophobic effect, complexity and emergence, surface science, microfluidics, paper as a material, self-assembly, micro- and nanotechnology, healthcare for developing economies, catalysis, origin of life, dissipatice systems, soft robotics, rational drug design, simplicity, and infochemistry. Innoviva Inc (INVA) Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. Manoj K. Chaudhury and George M. Whitesides Authors Info & Affiliations. The estimated Net Worth of George M Whitesides is at least $383 Thousand dollars as of 11 August 2017. In 1998, he received the U.S. National Medal of Science, In 2003, the Kyoto Prize in Materials Science and Engineering and in 2005, the Welch Award in Chemistry. . Whitesides has worked on advisory committees for the National Science Foundation known as NASA and the Department of Defense. [29], Whitesides has served on advisory committees for the National Science Foundation, NASA, and the Department of Defense. His surface chemistry work has examined the process of molecules arranging themselves on a surface. of 65,000 shares made by Andrew A. Hindman Postdoctoral Fellow, Harvard University, G. M. Whitesides Group. . Whitesides. George T. Whitesides Wife. Highlights of Research and Education Contributions (12/5/18): Graduate students: 168 graduated, 2 current; Post docs: 293 total, 18 current, Trainees in academic positions: 64 (last 10 yrs); Startup companies founded: 10 (last 10 yrs); New jobs created: ~1,000, Web of Science (WoS): h-index: 213; Total citations 196,416, Copyright 2023 The President and Fellows of Harvard College, Adaptive Materials, Composites and Polymers, Density as a Tool for Chemistry and Biology, Diagnostics, Bioanalytics and other Tools for Global Health, Microfluidics in Polymers, Paper, and Thread, Soft Lithography and Unconventional Nanofabrication. Browse the library of TED talks and speakers. If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. George M Whitesides owns 237,054 shares of Theravance Biopharma Inc (TBPH) as of August 11, 2017, with a value of $2 Million. Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. The report addressed U.S. competitiveness in science and technology. Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. purchase A design (with diameters of channels 20 m) is created in a The gurus listed in this website are not affiliated with GuruFocus.com, LLC. and George Whitesides attended Princeton University, graduating from the Woodrow Wilson School of Public and International Affairs. Sunday Foster. George M Whitesides is the director of Theravance Biopharma Inc. Andres W Martinez 1 , Scott T Phillips, George M Whitesides, Emanuel Carrilho. [8], Last edited on 27 February 2023, at 16:51, Publishing Your Research 101 Impact of technology on scientific articles, Talking Nano: Perspectives on Nanotechnology (1 of 4), The Courage to Go Off and Start New Things, American Association for the Advancement of Science, Royal Netherlands Academy of Arts and Sciences, F. A.

Nashville Stars Travel Baseball, Dready Brian Crestone Co, Caustic Soda Poundland, Rosewe Catalog Request, Queensbury Tip Opening Times, Articles G